Kantoff PW - Search Results

1

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.

Xie W, Regan MM, Buyse M, Halabi S, Kantoff PW, Sartor O, Soule H, Berry D, Clarke N, Collette L, D'Amico A, Lourenco RA, Dignam J, Eisenberger M, James N, Fizazi K, Gillessen S, Loriot Y, Mottet N, Parulekar W, Sandler H, Spratt DE, Sydes MR, Tombal B, Williams S, Sweeney CJ; ICECaP Working Group. Xie W, et al. Among authors: kantoff pw. J Clin Oncol. 2020 Sep 10;38(26):3032-3041. doi: 10.1200/JCO.19.03114. Epub 2020 Jun 18. J Clin Oncol. 2020. PMID: 32552276 Free PMC article.

2

Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?

Richie JP, Kantoff PW. Richie JP, et al. Among authors: kantoff pw. J Clin Oncol. 1991 Aug;9(8):1393-6. doi: 10.1200/JCO.1991.9.8.1393. J Clin Oncol. 1991. PMID: 2072143

3

Detection of circulating tumor cells in men with localized prostate cancer.

Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Seiden MV, et al. Among authors: kantoff pw. J Clin Oncol. 1994 Dec;12(12):2634-9. doi: 10.1200/JCO.1994.12.12.2634. J Clin Oncol. 1994. PMID: 7527455

4

14-Day continuous infusion of mitoxantrone in hormone-refractory metastatic adenocarcinoma of the prostate.

Kantoff PW, Block C, Letvak L, George M. Kantoff PW, et al. Am J Clin Oncol. 1993 Dec;16(6):489-91. doi: 10.1097/00000421-199312000-00005. Am J Clin Oncol. 1993. PMID: 8256762 Clinical Trial.

5

Rate of relapse following treatment for localized prostate cancer: a critical analysis of retrospective reports.

Coleman CN, Beard CJ, Kantoff PW, Gelman R. Coleman CN, et al. Among authors: kantoff pw. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):303-13. doi: 10.1016/0360-3016(94)90171-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 8270455 Review.

6

Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.

Smith MR, Kantoff PW. Smith MR, et al. Among authors: kantoff pw. Semin Oncol. 1995 Dec;22(6):625-32. Semin Oncol. 1995. PMID: 8539637 Review.

7

The prostate specific antigen. Its use as a tumor marker for prostate cancer.

Kantoff PW, Talcott JA. Kantoff PW, et al. Hematol Oncol Clin North Am. 1994 Jun;8(3):555-72. Hematol Oncol Clin North Am. 1994. PMID: 8707772 Review.

8

Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinoma.

Kibel AS, Krithivas K, Shamel LB, Kantoff PW, DeWolf WC. Kibel AS, et al. Among authors: kantoff pw. Urology. 1996 Nov;48(5):741-6. doi: 10.1016/S0090-4295(96)00235-X. Urology. 1996. PMID: 8911518

9

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma.

Ghossein RA, Rosai J, Scher HI, Seiden M, Zhang ZF, Sun M, Chang G, Berlane K, Krithivas K, Kantoff PW. Ghossein RA, et al. Among authors: kantoff pw. Urology. 1997 Jul;50(1):100-5. doi: 10.1016/S0090-4295(97)00127-1. Urology. 1997. PMID: 9218026

10

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.

Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, Wishnow KI, Kaplan I, Loughlin KR, Richie JP, Kantoff PW. Talcott JA, et al. Among authors: kantoff pw. J Clin Oncol. 1998 Jan;16(1):275-83. doi: 10.1200/JCO.1998.16.1.275. J Clin Oncol. 1998. PMID: 9440753

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters